Medicine & Life Sciences
Neoplasms
100%
Renal Cell Carcinoma
65%
Therapeutics
45%
Non-Small Cell Lung Carcinoma
43%
Diphtheria Toxin
37%
Survival
35%
Mutation
34%
Acute Myeloid Leukemia
31%
Immunotoxins
31%
Lung Neoplasms
30%
Drug Therapy
29%
palmitoyl-protein thioesterase
29%
Proteins
28%
Breast Neoplasms
28%
Glioblastoma
25%
Ricin
24%
Genes
22%
Immunotherapy
21%
Brain Neoplasms
20%
Neoplasm Metastasis
20%
Clinical Trials
19%
Safety
19%
Melanoma
18%
Prostatic Neoplasms
18%
Nivolumab
18%
Radiotherapy
18%
Progression-Free Survival
17%
Leukemia
17%
Glioma
17%
Pharmaceutical Preparations
16%
Ceroid lipofuscinosis, neuronal 1, infantile
16%
anthrax toxin
16%
Growth
16%
Cell Line
15%
Bone Marrow
15%
Huntingtin Protein
14%
Enzymes
14%
Neuronal Ceroid-Lipofuscinoses
13%
Granulocyte-Macrophage Colony-Stimulating Factor
13%
T-Lymphocytes
13%
ErbB Receptors
13%
Brain
13%
Colorectal Neoplasms
13%
Stem Cells
12%
Isocitrate Dehydrogenase
12%
Kidney Neoplasms
12%
Sickle Cell Anemia
12%
Liver
11%
Monoclonal Antibodies
11%
Antibodies
11%
alpha-hydroxyglutarate
11%
In Vitro Techniques
11%
Recurrence
11%
Small Cell Lung Carcinoma
11%
Blood Platelets
11%
Graft vs Host Disease
11%
Heterografts
11%
Thrombosis
11%
Interleukin-3
10%
Sunitinib
10%
Protein-Tyrosine Kinases
10%
Adenocarcinoma
10%
Transplants
10%
DNA
10%
Pharmacokinetics
10%
Population
10%
Biomarkers
9%
Carcinogenesis
9%
Apoptosis
9%
Bone Marrow Transplantation
9%
Bevacizumab
9%
Confidence Intervals
9%
Vitamin B 12
9%
Blood-Brain Barrier
9%
Vascular Endothelial Growth Factor A
9%
Radiosurgery
9%
Interleukin-3 Receptors
9%
Pancreatic Neoplasms
9%
Fluorouracil
8%
Docetaxel
8%
Barrett Esophagus
8%
Kidney
8%
Interleukin-2
8%
Thrombocytopenia
8%
Tissue Donors
8%
Lung
8%
Cisplatin
8%
Lymphoma
8%
bavituximab
8%
Peptides
8%
Radiation
8%
Ipilimumab
8%
Hematologic Neoplasms
8%
Maximum Tolerated Dose
8%
Multiple Myeloma
8%
Capecitabine
7%
Erlotinib Hydrochloride
7%
Safety-net Providers
7%
Myeloid Cells
7%
Serum
7%